MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
14 hedge funds and large institutions have $987K invested in Stealth BioTherapeutics Corp. ADS in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Goldman Sachs
New York
|
$0 |
2 |
UBS Group
Zurich,
Switzerland
|
$1K |
3 |
Renaissance Technologies
New York
|
$91K |
4 |
PAM
PVG Asset Management
Golden,
Colorado
|
$0 |
5 |
BFM
Boothbay Fund Management
New York
|
$66K |